Skip to main content
SpringerLink
Log in

Carotid plaque, stroke pathogenesis, and CRP: Treatment of ischemic stroke

  • Published:
Current Cardiology Reports Aims and scope Submit manuscript

Abstract

C-reactive protein (CRP), an inflammatory marker, has been identified as a likely predictor of the risk of a future stroke. In clinical settings, it has been consistently observed that higher concentrations of CRP are associated with larger brain infarcts and worst neurologic outcome. However, there is still controversy over the degree of risk conferred by elevated CRP concentrations. CRP, like many other hemostatic factors, is an acute-phase protein and, therefore, it is not always clear whether its association with cerebrovascular disease reflects its contribution to atherothrombosis, its acute-phase condition, or both. Whether a reduction of CRP levels could be beneficial to stroke patients remains to be clarified. More studies are needed before CRP becomes a routine part of the evaluation of stroke patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Wagner DD: New links between inflammation and thrombosis. Arterioscler Thromb Vasc Biol 2005, 25:1321–1324.

    Article  PubMed  CAS  Google Scholar 

  2. Stoll G, Bendszus M: Inflammation and atherosclerosis: novel insights into plaque formation and destabilization. Stroke 2006, 37:1923–1932.

    Article  PubMed  CAS  Google Scholar 

  3. Ridker PM, Rifai N, Rose L, et al.: Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med 2002, 347:1557–1565.

    Article  PubMed  CAS  Google Scholar 

  4. Krupinski J, Turu MM, Martínez-González J, et al.: Endogenous expression of C-reactive protein is increased in active (ulcerated non-complicated) human carotid artery plaques. Stroke 2006, 37:1200–1204.

    Article  PubMed  CAS  Google Scholar 

  5. Montero I, Orbe J, Varo N, et al.: C-reactive protein induces matrix metalloproteinase-1 and-10 in human endothelial cells: implications for clinical and subclinical atherosclerosis. J Am Coll Cardiol 2006, 47:1369–1378.

    Article  PubMed  CAS  Google Scholar 

  6. Pepys MB, Hirschfield GM: C-reactive protein: a critical update. J Clin Invest 2003, 111:1805–1812.

    Article  PubMed  CAS  Google Scholar 

  7. Black S, Kushner I, Samols D: C-reactive protein. J Biol Chem 2004, 279:48487–48490.

    Article  PubMed  CAS  Google Scholar 

  8. Smith CJ, Emsley HC, Gavin CM, et al.: Peak plasma interleukin-6 and other peripheral markers of inflammation in the first week of ischaemic stroke correlate with brain infarct volume, stroke severity and long-term outcome. BMC Neurol 2004, 4:2.

    Article  PubMed  Google Scholar 

  9. Flex A, Gaetani E, Papaleo P, et al.: Proinflammatory genetic profiles in subjects with history of ischemic stroke. Stroke 2004, 35:2270–2275.

    Article  PubMed  CAS  Google Scholar 

  10. Grocott HP, White WD, Morris RW, et al.: Genetic polymorphisms and the risk of stroke after cardiac surgery. Stroke 2005, 36:1854–1858.

    Article  PubMed  CAS  Google Scholar 

  11. Danesh J, Wheeler JG, Hirschfield GM, et al.: C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med 2004, 350:1387–1397.

    Article  PubMed  CAS  Google Scholar 

  12. Paul A, Yeh ET, Chan L: A proatherogenic role for C-reactive protein in vivo. Curr Opin Lipidol 2005, 16:512–517.

    Article  PubMed  CAS  Google Scholar 

  13. Han KH, Hong KH, Park JH, et al.: C-reactive protein promotes monocyte chemoattractant protein-1-mediated chemotaxis through upregulating CC chemokine receptor 2 expression in human monocytes. Circulation 2004, 109:2566–2571.

    Article  PubMed  CAS  Google Scholar 

  14. Pasceri V, Cheng JS, Willerson JT, et al.: Modulation of C-reactive protein-mediated monocyte chemoattractant protein-1 induction in human endothelial cells by antiatherosclerosis drugs. Circulation 2001, 103:2531–2534.

    PubMed  CAS  Google Scholar 

  15. Clapp BR, Hirschfield GM, Storry C, et al.: Inflammation and endothelial function: direct vascular effects of human C-reactive protein on nitric oxide bioavailability. Circulation 2005, 111:1530–1536.

    Article  PubMed  Google Scholar 

  16. Cirillo P, Golino P, Calabro P, et al.: C-reactive protein induces tissue factor expression and promotes smooth muscle and endothelial cell proliferation. Cardiovasc Res 2005, 68:47–55.

    Article  PubMed  CAS  Google Scholar 

  17. Blaschke F, Bruemmer D, Yin F, et al.: C-reactive protein induces apoptosis in human coronary vascular smooth muscle cells. Circulation 2004, 110:579–587.

    Article  PubMed  CAS  Google Scholar 

  18. Jabs WJ, Theissing E, Nitschke M, et al.: Local generation of C-reactive protein in diseased coronary artery venous bypass grafts and normal vascular tissue. Circulation 2003, 108:1428–1431.

    Article  PubMed  CAS  Google Scholar 

  19. Calabro P, Willerson JT, Yeh ET: Inflammatory cytokines stimulated C-reactive protein production by human coronary artery smooth muscle cells. Circulation 2003, 108:1930–1932.

    Article  PubMed  CAS  Google Scholar 

  20. Venugopal SK, Devaraj S, Jialal I: Macrophage conditioned medium induces the expression of C-reactive protein in human aortic endothelial cells: potential for paracrine/autocrine effects. Am J Pathol 2005, 166:1265–1271.

    PubMed  CAS  Google Scholar 

  21. Sattler KJ, Woodrum JE, Galili O, et al.: Concurrent treatment with renin-angiotensin system blockers and acetylsalicylic acid reduces nuclear factor kappaB activation and C-reactive protein expression in human carotid artery plaques. Stroke 2005, 36:14–20.

    Article  PubMed  CAS  Google Scholar 

  22. Inoue T, Kato T, Uchida T, et al.: Local release of C-reactive protein from vulnerable plaque or coronary arterial wall injured by stenting. J Am Coll Cardiol 2005, 46:239–245.

    Article  PubMed  CAS  Google Scholar 

  23. Chapman CM, Beilby JP, McQuillan BM, et al.: Monocyte count, but not C-reactive protein or interleukin-6, is an independent risk marker for subclinical carotid atherosclerosis. Stroke 2004, 35:1619–1624.

    Article  PubMed  CAS  Google Scholar 

  24. Van Der Meer IM, De Maat MP, Hak AE, et al.: C-reactive protein predicts progression of atherosclerosis measured at various sites in the arterial tree: the Rotterdam Study. Stroke 2002, 33:2750–2755.

    Article  Google Scholar 

  25. Di Napoli M, Schwaninger M, Cappelli R, et al.: Evaluation of C-reactive protein measurement for assessing the risk and prognosis in ischemic stroke: a statement for health care professionals from the CRP Pooling Project members. Stroke 2005, 36:1316–1329.

    Article  PubMed  Google Scholar 

  26. Corrado E, Rizzo M, Tantillo R, et al.: Markers of inflammation and infection influence the outcome of patients with baseline asymptomatic carotid lesions: a 5-year follow-up study. Stroke 2006, 37:482–486.

    Article  PubMed  CAS  Google Scholar 

  27. Arenillas JF, Alvarez-Sabin J: Basic mechanisms in intracranial large-artery atherosclerosis: advances and challenges. Cerebrovasc Dis 2005, 20(suppl 2):75–83.

    Article  PubMed  Google Scholar 

  28. de Maat MP, Trion A: C-reactive protein as a risk factor versus risk marker. Curr Opin Lipidol 2005, 15:651–657.

    Article  Google Scholar 

  29. Di Napoli M, Papa F: C-reactive protein and cerebral small-vessel disease: an opportunity to reassess small-vessel disease physiopathology? Circulation 2005, 112:781–785.

    Article  PubMed  Google Scholar 

  30. van Dijk EJ, Prins ND, Vermeer SE, et al.: C-reactive protein and cerebral small-vessel disease: the Rotterdam Scan Study. Circulation 2005, 112:900–905.

    Article  PubMed  Google Scholar 

  31. Tanne D, Benderly M, Goldbourt U, et al.: C-reactive protein as a predictor of incident ischemic stroke among patients with preexisting cardiovascular disease. Stroke 2006, 37:1720–1724.

    Article  PubMed  CAS  Google Scholar 

  32. Kuo HK, Yen CJ, Chang CH, et al.: Relation of C-reactive protein to stroke, cognitive disorders, and depression in the general population: systematic review and meta-analysis. Lancet Neurol 2005, 4:371–380.

    Article  PubMed  CAS  Google Scholar 

  33. Linnemann B, Voigt W, Nobel W, Janka HU: C-reactive protein is a strong independent predictor of death in type 2 diabetes: association with multiple facets of the metabolic syndrome. Exp Clin Endocrinol Diabetes 2006, 114:127–134.

    Article  PubMed  CAS  Google Scholar 

  34. Woodward M, Lowe GD, Campbell DJ, et al.: Associations of inflammatory and hemostatic variables with the risk of recurrent stroke. Stroke 2005, 36:2143–2147.

    Article  PubMed  Google Scholar 

  35. Danesh J, Lewington S, Thompson SG, et al.: Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis. Fibrinogen Studies Collaboration. JAMA 2005, 294:1799–1809.

    Article  PubMed  CAS  Google Scholar 

  36. Pearson TA, Mensah GA, Alexander RW, et al.: Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 2003, 107:499–511.

    Article  PubMed  Google Scholar 

  37. Emsley HC, Smith CJ, Gavin CM, et al.: An early and sustained peripheral inflammatory response in acute ischaemic stroke: relationships with infection and atherosclerosis. J Neuroimmunol 2003, 139:93–101.

    Article  PubMed  CAS  Google Scholar 

  38. Ladenvall C, Jood K, Blomstrand C, et al.: Serum C-reactive protein concentration and genotype in relation to ischemic stroke subtype. Stroke 2006, 37:2018–2023.

    Article  PubMed  CAS  Google Scholar 

  39. Ridker PM: High-sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease. Circulation 2001, 103:1813–1818.

    PubMed  CAS  Google Scholar 

  40. Horowitz GL, Beckwith BA: C-reactive protein in the prediction of cardiovascular disease. N Engl J Med 2000, 343:512–513.

    Article  PubMed  CAS  Google Scholar 

  41. Bos MJ, Schipper CM, Koudstaal PJ, et al.: High serum C-reactive protein level is not an independent predictor for stroke: the Rotterdam Study. Circulation 2006, 114:1591–1598.

    Article  PubMed  CAS  Google Scholar 

  42. Audebert HJ, Rott MM, Eck T, Haberl RL: Systemic inflammatory response depends on initial stroke severity but is attenuated by successful thrombolysis. Stroke 2004, 35:2128–2133.

    Article  PubMed  Google Scholar 

  43. Schillaci G, Pirro M: C-reactive protein in hypertension: clinical significance and predictive value. Nutr Metab Cardiovasc Dis 2006, 16:500–508.

    Article  PubMed  Google Scholar 

  44. Prasad K: C-reactive protein (CRP)-lowering agents. Cardiovasc Drug Rev 2006, 24:33–50.

    Article  PubMed  CAS  Google Scholar 

  45. Di Napoli M, Papa F: Systemic inflammation, blood pressure, and stroke outcome. J Clin Hypertens (Greenwich) 2006, 8:187–194.

    Article  Google Scholar 

  46. Yeh ET, Khan BV: The potential role of antiplatelet agents in modulating inflammatory markers in atherothrombosis. J Thromb Haemost 2006, 4:2308–2316.

    Article  PubMed  CAS  Google Scholar 

  47. Yin MJ, Yamamoto Y, Gaynor RB.: The anti-inflammatory agents aspirin and salicylate inhibit the activity of I(kappa)B kinase-beta. Nature 1998, 396:77–80.

    Article  PubMed  CAS  Google Scholar 

  48. Di Napoli M, Papa F: Inflammation, statins, and outcome after ischemic stroke. Stroke 2001, 32:2446–2447.

    PubMed  Google Scholar 

  49. Ridker PM, Cannon CP, Morrow D, et al.: C-reactive protein levels and outcomes after statin therapy. Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 (PROVE IT-TIMI 22) Investigators. N Engl J Med 2005, 352:20–28.

    Article  PubMed  CAS  Google Scholar 

  50. Mega JL, Morrow DA, Cannon CP, et al.: Cholesterol, C-reactive protein, and cerebrovascular events following intensive and moderate statin therapy. J Thromb Thrombolysis 2006, 22:71–76.

    Article  PubMed  CAS  Google Scholar 

  51. Avellone GV, Di Garbo, Abruzzese G, et al.: One-year atorvastatin treatment in hypercholesterolemic patients with or without carotid artery disease. Int Angiol 2006, 25:26–34.

    PubMed  CAS  Google Scholar 

  52. Gotto AM Jr: Statins and C-reactive protein: considering a novel marker of cardiovascular risk. Prev Cardiol 2006, 5:200–203.

    Article  Google Scholar 

  53. Montaner J, Fernandez-Cadenas I, Molina CA, et al.: Poststroke C-reactive protein is a powerful prognostic tool among candidates for thrombolysis. Stroke 2006, 37:1205–1210.

    Article  PubMed  CAS  Google Scholar 

  54. Topakian R, Aichner FT, Haring HP: Admission C-reactive protein as a predictor for stroke outcome among candidates for thrombolysis: decision adjourned. Stroke 2006, 37:2454; author reply 2455–2456.

    Article  PubMed  Google Scholar 

  55. Ridker PM, Hennekens CH, Buring JE, Rifai N: C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 2000, 342:836–843.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurology, Stroke Unit, Hospital Universitari de Bellvitge, Feixa Llarga s/n 08907 L’Hospitalet de Llobregat, Barcelona, Spain

    Jerzy Krupinski

Authors
  1. Jerzy Krupinski
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Marta M. Turu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Mark Slevin
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. José Martínez-González
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jerzy Krupinski.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Krupinski, J., Turu, M.M., Slevin, M. et al. Carotid plaque, stroke pathogenesis, and CRP: Treatment of ischemic stroke. Curr Cardiol Rep 10, 25–30 (2008). https://doi.org/10.1007/s11886-008-0006-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11886-008-0006-4

Keywords

Search

Navigation